Clinical Trial Results

Showing: All studies [change]
Condition: Hypertension Location: Richmond, Virginia 13 trials found
New Search
Filter
Trial Phase
Study Type
Pulmonary Hypertension Association Registry
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
PHASE3INTERVENTIONAL Fresno, California +4 more
RECRUITING
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
PHASE1, PHASE2INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3INTERVENTIONAL Fairhope, Alabama +4 more
RECRUITING
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
PHASE2INTERVENTIONAL Foley, Alabama +4 more
RECRUITING
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Autonomic and Renal Contributions to Hypertension With ADT
PHASE4INTERVENTIONAL Richmond, Virginia
RECRUITING
Filter Trials
Trial Phase
Study Type